Literature DB >> 17465479

Screening for metronidazole-resistance associated gene fragments of H pylori by suppression subtractive hybridization.

Ai-Qing Li1, Ning Dai, Jie Yan, Yong-Liang Zhu.   

Abstract

AIM: To screen for metronidazole (MTZ)-resistance associated gene fragments of H pylori by suppression subtractive hybridization (SSH).
METHODS: Five MTZ-resistant (tester, T) and 1 MTZ-susceptible (driver, D) clinical H pylori isolates were selected. Genomic DNAs were prepared and submitted to Rsa I digestion. Then two different adaptors were ligated respectively to the 5'-end of two aliquots of the tester DNA fragments and SSH was made between the tester and driver DNAs. The specific inserts of tester strains were screened and MTZ-resistance related gene fragments were identified by dot blotting.
RESULTS: Among the randomly selected 120 subtractive colonies, 37 DNA fragments had a different number of DNA copies (> or = 2 times) in resistant and susceptible strains and 17 of them had a significantly different number of DNA copies (> or = 3 times). Among the sequences obtained from the 17 DNA fragments, new sequences were found in 10 DNA fragments and duplicated sequences in 7 DNA fragments, representing respectively the sequences of depeptide ABC transporter periplasmic dipeptide-binding protein (dppA), permease protein (dppB), ribosomal protein S4 (rps4), ribonuclease III (rnc), protease (pqqE), diaminopimelate epimerase (dapF), acetatekinase (ackA), H pylori plasmid pHP51 and H pylori gene 1334.
CONCLUSION: Gene fragments specific to MTZ-resistant H pylori strains can be screened by SSH and may be associated with MTZ-resistant H pylori.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465479      PMCID: PMC4149965          DOI: 10.3748/wjg.v13.i12.1847

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  [Cloning and identification of deltamethrin-resistance or susceptibility associated genes of Culex pipiens pallens].

Authors:  H S Tian; C L Zhu; X H Gao; L Ma; B Shen; X L Li; G L Wu
Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi       Date:  2001

Review 2.  Bacterial periplasmic permeases belong to a family of transport proteins operating from Escherichia coli to human: Traffic ATPases.

Authors:  G F Ames; C S Mimura; V Shyamala
Journal:  FEMS Microbiol Rev       Date:  1990-08       Impact factor: 16.408

3.  Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

4.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Identification and localization of differences between Escherichia coli and Salmonella typhimurium genomes by suppressive subtractive hybridization.

Authors:  M L Bogush; T V Velikodvorskaya; Y B Lebedev; L G Nikolaev; S A Lukyanov; A F Fradkov; B K Pliyev; M N Boichenko; G N Usatova; A A Vorobiev; G L Andersen; E D Sverdlov
Journal:  Mol Gen Genet       Date:  1999-12

6.  Molecular analysis of genetic differences between virulent and avirulent strains of Aeromonas hydrophila isolated from diseased fish.

Authors:  Y L Zhang; C T Ong; K Y Leung
Journal:  Microbiology       Date:  2000-04       Impact factor: 2.777

7.  Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

Authors:  D H Kwon; F A El-Zaatari; M Kato; M S Osato; R Reddy; Y Yamaoka; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  [Correlation of rdxA gene mutation and metronidazole resistance of Helicobacter pylori].

Authors:  Ning Dai; Gang Zhou; Jie Yan
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2003-02

9.  Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase.

Authors:  A Goodwin; D Kersulyte; G Sisson; S J Veldhuyzen van Zanten; D E Berg; P S Hoffman
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

10.  Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance.

Authors:  Stephanie A Chisholm; Robert J Owen
Journal:  J Antimicrob Chemother       Date:  2003-03-13       Impact factor: 5.790

View more
  3 in total

1.  Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Helicobacter pylori Infection in the Dominican Republic.

Authors:  Muhammad Miftahussurur; Modesto Cruz; Phawinee Subsomwong; José A Jiménez Abreu; Celso Hosking; Hiroyuki Nagashima; Junko Akada; Yoshio Yamaoka
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.

Authors:  Muhammad Miftahussurur; Pradeep Krishna Shrestha; Phawinee Subsomwong; Rabi Prakash Sharma; Yoshio Yamaoka
Journal:  BMC Microbiol       Date:  2016-11-04       Impact factor: 3.605

3.  Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.

Authors:  Muhammad Miftahussurur; Ari Fahrial Syam; Iswan Abbas Nusi; Dadang Makmun; Langgeng Agung Waskito; Lukman Hakim Zein; Fardah Akil; Willy Brodus Uwan; David Simanjuntak; I Dewa Nyoman Wibawa; Jimmy Bradley Waleleng; Alexander Michael Joseph Saudale; Fauzi Yusuf; Syifa Mustika; Pangestu Adi; Ummi Maimunah; Hasan Maulahela; Yudith Annisa Ayu Rezkitha; Phawinee Subsomwong; Dadik Rahardjo; Rumiko Suzuki; Junko Akada; Yoshio Yamaoka
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.